(EMAILWIRE.COM, December 08, 2018 ) The major players in the adhesion barrier market are Johnson & Johnson (J&J) (US), Sanofi (France), Baxter International (US), C.R. Bard (US), Integra LifeSciences (US), Anika Therapeutics (US), Atrium Medical Corporation (US), FzioMed (US), MAST Biosurgery (Switzerland), Innocoll Holdings (Ireland), Betatech Medical (Turkey), SyntheMed (US), Aziyo Biologics (US), Biom’up (France), Terumo Corporation (Japan), and BMI Korea Co. (South Korea).

The growth of this market is driven by the growth in the geriatric population and corresponding age-related chronic diseases, epidemiological shift from infectious to chronic diseases, growing volume of surgical procedures and sports-related injuries, and increasing awareness about the medical complications occurred due to post-surgical adhesion formation.

Speak To Analyst For More Details:
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=208132543

By application, the adhesion barrier market is segmented into gynecological surgeries, general/abdominal surgeries, cardiovascular surgeries, orthopedic surgeries, neurological surgeries, reconstructive surgeries, urological surgeries, and other surgeries (such as ear, nose, throat, and burn surgeries). The gynecological segment accounted for the largest share of the market in 2017. Factors such as the increasing number of C-section surgeries, rising incidence of pelvic/uterine cancer, and increasing prevalence of conditions such as infertility and incontinence responsible to drive this market.

You will get:
What are the Known and Unknown Adjacencies Impacting the Adhesion Barrier Market

What will your New Revenue Sources be?

Who will be your Top Customer and what will make them switch?

Strategies to Defend your Market Share or Win Competitors.

Request FREE Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=208132543